54 Bivirkninger var ensartede mellem patienter, der fik 400 mg REYATAZ én gang dagligt, og patienter, der fik 300 mg REYATAZ med ritonavir 100 mg én gang dagligt, med undtagelse af, at der hyppigere indberettedes gulsot og forhøjede niveauer af totalbilirubin ved REYATAZ plus ritonavir.
Adverse reactions were consistent between patients who received REYATAZ 400 mg once daily and patients who received REYATAZ 300 mg with ritonavir 100 mg once daily, except that jaundice and elevated total bilirubin levels were reported more frequently with REYATAZ plus ritonavir.